[ad_1]
He Comptroller General, Carlos Felipe Córdoba, warned about a series of irregular situations that are affecting the Health System and to which attention should be paid, starting with the recovery of medicines that exceed up to 8,000% the maximum price allowed.
The agency noted that There are three EPS that account for 60% of the sum of recoveries drawn in nine months. Is about New EPS, Sanitas and Suramericana, which accumulate recoveries amounting to 906,000 million pesos, for medicines for the five main high-cost diseases.
“This is the case of Doxopeg, a drug used in the treatment of ovarian cancer, the same is the case with two drugs used in the treatment of von Willebrand disease, with recoveries of 6,000 and 3,000%, respectively“Said the head of the control body.
Read also: In August the recovery that the country’s economy had been showing was halted
The watchdog It also found that four EPS turn preferentially to a drug supplier, with what could be configuring in the health market the presence of ‘oligopolies’ in providers.
“We will not allow privileges or illegal concentration of resources in the hands of those who find themselves in crisis, not an opportunity to solve structural problems, but to do business, “warned the Comptroller.
You may be interested in: Government issues third warning about express pension transfer project
On the other hand, The head of the agency affirmed that progress has been very slow in repairing the health sector debt, through the Final Point Agreement, since only 1.5 trillion pesos of the 6.7 billion pesos projected for this purpose have been effectively paid.
Finally, Córdoba expressed concern about the fact that Colombia has lost sovereignty in the production of vaccines since the implementation of Law 100 of 1993, a situation that asked to be corrected in the future.
